Skip to main content

Multimodal imaging in parkinsonisms: from the molecular synaptic pruning to the whole-brain connectomics

Project description

Imaging technology to improve diagnostic of Parkinsonism

Parkinsonism is the second most prevalent neurodegenerative disorder after Parkinson’s disease (PD), and 20 % of patients are diagnosed with atypical parkinsonisms (AP). AP tends to be therapy-resistant and presents a faster degeneration rate than PD. The EU-funded SYNPARK project is an interdisciplinary action that will investigate the value of the different imaging markers' modalities in various parkinsonism forms. Improving diagnostic accuracy is important now, when disease-modifying therapies are becoming available for PD. The research involves a multidisciplinary approach of the in vivo synaptic molecular brain assessment using positron emission tomography (PET), the whole-brain connectomics organisation using magnetic resonance imaging and the clinical validation of a new generation PET tracer in AP/PD.

Coordinator

UNIVERSITAT DE BARCELONA
Net EU contribution
€ 232 497,60
Address
Gran Via De Les Corts Catalanes 585
08007 Barcelona
Spain

See on map

Region
Este Cataluña Barcelona
Activity type
Higher or Secondary Education Establishments
Other funding
€ 232 497,60

Partners (1)

Partner

Partner organisations contribute to the implementation of the action, but do not sign the Grant Agreement.

CENTRE FOR ADDICTION AND MENTAL HEALTH
Canada
Net EU contribution
€ 0,00
Other funding
€ 0,00